Life Sciences Intellectual Property Review announces the details of the 6th annual LSPN North America–Spring Conference that being held from May 8-9, 2024, in Boston, Massachusetts.

The two-day event brings together in-house counsel from the world’s leading pharmaceutical and biotechnology companies. Sterne Kessler Director, Eldora Ellison, is the chairperson of the event, and she remarks “I am delighted that this conference brings together over 200 attendees from around the world, spanning the breadth of pharma, biotech, and medtech companies.  Our speakers will provide practical guidance and updates on topics such as the Unified Patent Court (UPC), patent strategies in view of clinical trial disclosures, multijurisdictional patent litigation, and mental health and IP.”

The sessions and panels at the event will cover a broad range of topics, including: patentability, eligibility, prosecution to litigation, and information about the full lifecycle of US patent protection. Details about the conference are available here.